AstraZeneca

AstraZeneca and Daiichi Sankyo Report Breakthrough Results for DATROWAY® in Advanced Breast Cancer Trial

WILMINGTON, DE — AstraZeneca and Daiichi Sankyo announced that their jointly developed therapy, DATROWAY® (datopotamab deruxtecan-dlnk), achieved positive top-line results in the Phase III TROPION-Breast02 trial, marking a major advancement …

AstraZeneca and Daiichi Sankyo Report Breakthrough Results for DATROWAY® in Advanced Breast Cancer Trial Read More